These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2129251

  • 21. Plasminogen activators and cancer.
    Duffy MJ.
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):681-7. PubMed ID: 2133247
    [Abstract] [Full Text] [Related]

  • 22. Profibrinolytic and antifibrinolytic effects of platelets.
    Devine DV, Carter CJ.
    Coron Artery Dis; 1995 Dec; 6(12):915-22. PubMed ID: 8723012
    [Abstract] [Full Text] [Related]

  • 23. Regulation of plasminogen activator production by endothelial cells: role in fibrinolysis and local proteolysis.
    van Hinsbergh VW, Kooistra T, Emeis JJ, Koolwijk P.
    Int J Radiat Biol; 1991 Dec; 60(1-2):261-72. PubMed ID: 1713938
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
    Pepper MS, Rosnoblet C, Di Sanza C, Kruithof EK.
    Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
    [Abstract] [Full Text] [Related]

  • 26. Letter: Effect of induced chronic intravascular coagulation on plasminogen activator in dogs.
    Owen CA.
    Thromb Diath Haemorrh; 1975 Sep 30; 34(1):309-11. PubMed ID: 1188714
    [No Abstract] [Full Text] [Related]

  • 27. Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system.
    Chen PR, Lee CC, Chang H, Tsai CE.
    J Nutr Biochem; 2005 Jan 30; 16(1):59-64. PubMed ID: 15629242
    [Abstract] [Full Text] [Related]

  • 28. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
    Gurewich V, Pannell R.
    Thromb Haemost; 1987 Jun 03; 57(3):372-3. PubMed ID: 3116707
    [No Abstract] [Full Text] [Related]

  • 29. [Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)].
    Hayashi T.
    Rinsho Byori; 1994 Apr 03; 42(4):346-51. PubMed ID: 8176842
    [Abstract] [Full Text] [Related]

  • 30. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep 03; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 31. Advances in clinical fibrinolysis.
    Hessel LW, Kluft C.
    Clin Haematol; 1986 May 03; 15(2):443-63. PubMed ID: 2942332
    [Abstract] [Full Text] [Related]

  • 32. [Regulatory mechanisms of PAI-1 on fibrinolysis in vascular endothelial cells].
    Sakata Y.
    Rinsho Byori; 1989 Apr 03; Spec No 81():149-55. PubMed ID: 2502640
    [No Abstract] [Full Text] [Related]

  • 33. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
    Páramo JA, Collen D.
    Sangre (Barc); 1984 Apr 03; 29(4-C):767-73. PubMed ID: 6393389
    [No Abstract] [Full Text] [Related]

  • 34. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H, Hagiya Y, Ueshima S, Okada K, Takaishi T, Izaki S, Matsuo O.
    Thromb Haemost; 1996 Feb 03; 75(2):352-8. PubMed ID: 8815589
    [Abstract] [Full Text] [Related]

  • 35. [Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].
    Páramo JA, Fernández FJ, Cuesta B, Paloma MJ, Rocha E.
    Sangre (Barc); 1989 Aug 03; 34(4):297-9. PubMed ID: 2505395
    [No Abstract] [Full Text] [Related]

  • 36. Tissue plasminogen activator-biologic perspective for surgeons.
    Chang R, Powell RJ, Sumpio BE.
    J Am Coll Surg; 1997 May 03; 184(5):529-39. PubMed ID: 9145078
    [No Abstract] [Full Text] [Related]

  • 37. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
    Nkere UU, Whawell SA, Thompson EM, Thompson JN, Taylor KM.
    J Thorac Cardiovasc Surg; 1993 Aug 03; 106(2):339-45. PubMed ID: 8341074
    [Abstract] [Full Text] [Related]

  • 38. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
    Matsuno H, Kozawa O, Niwa M, Ueshima S, Matsuo O, Collen D, Uematsu T.
    Thromb Haemost; 1999 Apr 03; 81(4):601-4. PubMed ID: 10235447
    [Abstract] [Full Text] [Related]

  • 39. [Mechanism of thrombolytic enzymes].
    Matsuo O.
    Rinsho Ketsueki; 1993 Apr 03; 34(4):395-402. PubMed ID: 8510325
    [Abstract] [Full Text] [Related]

  • 40. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC.
    Thromb Haemost; 1986 Aug 20; 56(1):35-9. PubMed ID: 3095946
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.